Perspective Chapter: Ethics of Using Placebo Controlled Trials for Covid-19 Vaccine Development in Vulnerable Populations
When clinical trials are conducted in vulnerable communities such as those found within low-to-middle-income-countries (LMICs), there is always the risk of exploitation or harm to these communities during the course of biomedical research. Historically, there have been multiple instances where signi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2022
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/81644 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Perspective Chapter: Ethics of Using Placebo Controlled Trials for Covid-19 Vaccine Development in Vulnerable Populations
- Placebo Use in Depression Research: Some Ethical Considerations
- Perspective Chapter: Multi-Omic Approaches to Vaccine Development against Helminth Diseases
- Introductory Chapter: Current Trends in Vaccine Development
- Vaccination against Human Papillomavirus (HPV) in Vulnerable Populations – Sexual Minorities
- Placebo Discontinuity Design
- A Machine Learning alternative to placebo-controlled clinical trials upon new diseases: A primer